Financhill
Back

ProShares UltraShort MidCap400 Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
25

MZZ
ProShares UltraShort MidCap400

Last Price:
$7.67
Seasonality Move:
-7.86%
Sell
38

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
25
ProShares UltraShort MidCap400 (MZZ) is a Sell

Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?

  • The current ProShares UltraShort MidCap400 [MZZ] share price is $7.92. The Score for MZZ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • MZZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MZZ Stock Price Chart

What is ProShares UltraShort MidCap400's stock price today?

  • The ProShares UltraShort MidCap400 share price today is $7.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

MZZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 49.24 Sell
Chaikin Money Flow: 1721 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.73 - 8.13) Sell
Bollinger Bands (100): (7.97 - 8.63) Sell

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.53 Buy
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 79100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 35.84) Sell
Bollinger Bands (100): (16.83 - 33.91) Buy

MZZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.76 Buy
20-day SMA: 7.87 Buy
50-day SMA: 8.17 Sell
200-day SMA: 9.19 Sell
8-day EMA: 7.79 Buy
20-day EMA: 7.9 Buy
50-day EMA: 7.97 Sell
200-day EMA: 5.43 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35 Sell
20-day SMA: 34.72 Sell
50-day SMA: 31.71 Buy
200-day SMA: 17.02 Buy
8-day EMA: 31.84 Buy
20-day EMA: 21.97 Buy
50-day EMA: 11.45 Buy
200-day EMA: 3.3 Buy

ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

ProShares UltraShort MidCap400 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):